Increased risk of recurrence and disease-specific death following delayed postoperative radiation for Merkel cell carcinoma

被引:2
作者
Alexander, Nora A. [1 ,2 ]
Schaub, Stephanie K. [3 ,4 ,6 ]
Goff, Peter H. [1 ]
Hippe, Daniel S. [4 ]
Park, Song Y. [1 ]
Lachance, Kristina [1 ]
Bierma, Marika [1 ]
Liao, Jay J. [4 ]
Apisarnthanarax, Smith [4 ]
Bhatia, Shailender [3 ,5 ]
Tseng, Yolanda D. [3 ,4 ]
Nghiem, Paul T. [1 ]
Parvathaneni, Upendra [3 ,4 ]
机构
[1] Univ Washington, Dept Med, Seattle, WA USA
[2] Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO USA
[3] Univ Washington, Dept Radiat Oncol, Seattle, WA USA
[4] Fred Hutchinson Canc Ctr, Clin Res Div, Seattle, WA USA
[5] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA USA
[6] Univ Washington, Sch Med, Dept Radiat Oncol, 1959 NE Pacific St Seattle, Seattle, WA 98195 USA
关键词
adjuvant; carcinoma; dermatologic surgical procedures; Merkel Cell; patient outcome; THERAPY; HEAD; RADIOTHERAPY; IRRADIATION; SURGERY; PATIENT; TIME;
D O I
10.1016/j.jaad.2023.07.1047
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Merkel cell carcinoma (MCC) is often treated with surgery and postoperative radiation therapy (PORT). The optimal time to initiate PORT (Time -to -PORT [ttPORT ]) is unknown. Purpose: We assessed if delays in ttPORT were associated with inferior outcomes. Methods: Competing risk regression was used to evaluate associations between ttPORT and locoregional recurrence (LRR) for patients with stage I/II MCC in a prospective registry and adjust for covariates. Distant metastasis and death were competing risks. Results: The cohort included 124 patients with median ttPORT of 41 days (range: 8-125 days). Median follow-up was 55 months. 17 (14%) patients experienced a LRR, 14 (82%) of which arose outside the radiation field. LRR at 5 years was increased for ttPORT [8 weeks vs # 8 weeks, 28.0% vs 9.2%, P = .006. There was an increase in the cumulative incidence of MCC-specific death with increasing ttPORT (HR = 1.14 per 1-week increase, P = .016). Limitations: The relatively low number of LRRs limited the extent of our multivariable analyses.
引用
收藏
页码:261 / 268
页数:8
相关论文
共 50 条
  • [41] Novel models by machine learning to predict the risk of cardiac disease-specific death in young patients with breast cancer
    Li, Yi
    Li, Handong
    Ye, Xuan
    Zhu, Zhigang
    Qiu, Yixuan
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [42] Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma
    Mo, Jeremy
    Zaremba, Anne
    Inderjeeth, Andrisha-Jade
    El Zeinaty, Perla
    Li, Ao
    Wicky, Alexandre
    Della Marta, Nicholas
    Marqueste, Caroline Gaudy
    Bohne, Ann-Sophie
    Matias, Margarida
    McNamee, Nicholas
    Festino, Lucia
    Chen, Charley
    Ch'ng, Sydney
    van Akkooi, Alexander C. J.
    Da Meda, Laetitia
    Park, John J.
    Ascierto, Paolo A.
    Hauschild, Axel
    Lee, Jenny H.
    Grob, Jean Jacques
    Mangana, Joanna
    Guminski, Alex
    Michielin, Olivier
    Xu, Wen
    Lebbe, Celeste
    Sandhu, Shahneen
    Zimmer, Lisa
    Menzies, Alexander M.
    Lo, Serigne N.
    Long, Georgina V.
    Carlino, Matteo S.
    da Silva, Ines Pires
    EUROPEAN JOURNAL OF CANCER, 2025, 217
  • [43] Cerebral metastasis of Merkel cell carcinoma following resection with negative margins and adjuvant external beam radiation: a case report
    Grubb, Alex F.
    Hankollari, Elizabeth
    JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [44] Higher Expression of Topoisomerase II Alpha Is an Independent Marker of Increased Risk of Cancer-specific Death in Patients with Clear Cell Renal Cell Carcinoma
    Parker, Alexander S.
    Eckel-Passow, Jeanette E.
    Serie, Daniel
    Hilton, Tracy
    Parasramka, Mansi
    Joseph, Richard W.
    Wu, Kevin J.
    Cheville, John C.
    Leibovich, Bradley C.
    EUROPEAN UROLOGY, 2014, 66 (05) : 929 - 935
  • [45] Intraoperative but not postoperative blood transfusion adversely affect cancer recurrence and survival following nephrectomy for renal cell carcinoma
    Abu-Ghanem, Yasmin
    Dotan, Zohar
    Zilberman, Dorit E.
    Kaver, Issac
    Ramon, Jacob
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [46] Oral squamous cell carcinoma: the impact of stage-dependent therapy regimes on postoperative disease recurrence
    Unterhuber, Tobias
    Duma, Marcia Nona
    Rau, Andrea
    Nieberler, Markus
    Wolff, Klaus-Dietrich
    Kesting, Marco Rainer
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2016, 121 (02): : 133 - 138
  • [47] Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence
    Rieken, Malte
    Kluth, Luis A.
    Fajkovic, Harun
    Capitanio, Umberto
    Briganti, Alberto
    Krabbe, Laura-Maria
    Margulis, Vitaly
    Abufaraj, Mohammad
    Mari, Andrea
    Foerster, Beat
    Raman, Jay D.
    Regelman, Mikhail
    Brookman-May, Sabine
    Sjoberg, Daniel D.
    Karakiewicz, Pierre, I
    Shariat, Shahrokh F.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (04) : E903 - E908
  • [48] Preoperative assessment of the risk of postoperative death in patients with oral squamous cell carcinoma: a consideration beyond age, sex, and stage of cancer
    Bartella, A. K.
    Sander, A. -K.
    Kamal, M.
    Steegmann, J.
    Kloss-Brandstatter, A.
    Teichmann, J.
    Hoelzlea, F.
    Lethaus, B.
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2018, 56 (04) : 322 - 326
  • [49] Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality
    Brunson, Ann
    Lei, Amy
    Rosenberg, Aaron S.
    White, Richard H.
    Keegan, Theresa
    Wun, Ted
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (02) : 319 - 326
  • [50] In-transit recurrence of Merkel cell carcinoma associated with Bowen's disease: The first reported case successfully treated by avelumab
    Kiyohara, Takahiro
    Shijimaya, Takako
    Miyamoto, Mari
    Nagano, Naoko
    Nakamaru, Sei
    Makimura, Kaoru
    Tanimura, Hirotsugu
    JOURNAL OF DERMATOLOGY, 2019, 46 (05) : 440 - 443